Search

Your search keyword '"toxoplasmosis"' showing total 11,922 results

Search Constraints

Start Over You searched for: Descriptor "toxoplasmosis" Remove constraint Descriptor: "toxoplasmosis" Publication Type Academic Journals Remove constraint Publication Type: Academic Journals
11,922 results on '"toxoplasmosis"'

Search Results

201. Choroidal Involvement in a Case of Viral Retinitis.

202. aControl and Prevention of Toxoplasmosis in Iran: A Policy Brief

203. Genetic diversity of Toxoplasma gondii in South America: occurrence, immunity, and fate of infection

204. Prevalence of Toxoplasma Gondii in Broiler Referred to Kashan Industrial Abattoir, Central Iran, 2023

205. Toxoplasmosis gestacional: desenlaces obstétricos y resultados perinatales en un hospital de referencia en Medellín, Colombia. 2015-2021. Un estudio descriptivo

206. Toxoplasma gondii seroprevalence in reindeer (Rangifer tarandus tarandus L.) in northern Sweden: a cross-sectional study from 2014

207. Antenatal Screening for Toxoplasmosis and Rubella in Saudi Arabia: Assessing the Need for Screening

208. Atypical pattern of ocular toxoplasmosis: recurrent inner foveal toxoplasmic retinitis (rifter)

209. Tissue cysts and serological detection toxoplasmosis among wild rats from Surabaya, East Java, Indonesia

210. Anti-Toxoplasma gondii screening of MMV pandemic response box and evaluation of RWJ-67657 efficacy in chronically infected mice

211. Seroprevalence of Toxoplasma gondii in Slaughtered Pigs in Kiambu, Kenya

212. Prevalencia de toxoplasmosis en niños de entre uno y seis años de edad

213. Functional Characterization of 11 Tentative Microneme Proteins in Type I RH Strain of Toxoplasma gondii Using the CRISPR-Cas9 System

214. Single Cell Expression Systems for the Production of Recombinant Proteins for Immunodiagnosis and Immunoprophylaxis of Toxoplasmosis

215. Interleukins IL33/ST2 and IL1-β in Intrauterine Growth Restriction and Seropositivity of Anti-Toxoplasma gondii Antibodies

218. TOXOPLASMOSE OCULAR E SUAS REPERCUSSÕES: UMA REVISÃO BIBLIOGRÁFICA.

219. Genetic diversity of Toxoplasma gondii in South America: occurrence, immunity, and fate of infection.

220. Toxoplasma gondii seroprevalence in reindeer (Rangifer tarandus tarandus L.) in northern Sweden: a cross-sectional study from 2014.

221. Newly optimized ELISA kit and LAT reveal significantly higher seroprevalence in sheep raised in agro-ecological zone as against range-ecological zone, with a significant association of meteorological parameters.

222. The splicing factor SR2 is an important virulence factor of Toxoplasma gondii.

223. بررسی میزان آلودگی به توکسوپلاسما گوندی در جوجه های گوشتی کشتار شده در کشتارگاه صنعتی کاشان، ۱۴۰۱.

224. کنترل و پیشگیری از توکسوپالسموز در ایران: خالصه سیاستی.

225. Gut commensal bacteria exacerbate toxoplasmosis associated with TgSheepCHn5 (ToxoDB#2) and TgRedpandaCHn1 (ToxoDB#20) through Th1 immune response.

226. Pediatric Posterior Infectious Uveitis.

227. CHANGES IN IMMUNE INDICATORS IN PATIENTS WITH CHRONIC TOXOPLASMOSIS.

228. Seroprevalence of Toxoplasma gondii , Neospora caninum and Trichinella spp. in Pigs from Cairo, Egypt.

229. Urtica dioica Extract Leads to Cyst Reduction, Enhanced Cell-Mediated Immune Response, and Antioxidant Activity in Experimental Toxoplasmosis.

230. A case of ocular toxoplasmosis presenting with neuroretinitis.

231. Seroprevalence of Toxoplasma gondii in Slaughtered Pigs in Kiambu, Kenya.

232. Human Anti-Toxoplasma Antibodies Attach Strongly to Breast Cancer Cells.

233. Lessons from a Multilaboratorial Task Force for Diagnosis of a Fatal Toxoplasmosis Outbreak in Captive Primates in Brazil.

234. Atypical pattern of ocular toxoplasmosis: recurrent inner foveal toxoplasmic retinitis (rifter).

235. Rapid and visual detection of Toxoplasma gondii oocyst in cat feces using loop-mediated isothermal amplification (LAMP) assay.

236. Congenital toxoplasmosis among hospitalized infants in Poland in the years 2007–2021: study based on the national hospital registry.

237. Performances of ICT Toxoplasma IgG-IgM test in comparison with Vidas® toxo competition to determine the immune status against Toxoplasma gondii.

238. Clinical and Metagenomic Characterization of Neurological Infections of People With Human Immunodeficiency Virus in the Peruvian Amazon.

239. Immunomodulatory, Antioxidant, and Anti-Inflammatory Activities of Green Synthesized Copper Nanoparticles for Treatment of Chronic Toxoplasma gondii Infection.

240. Association between toxoplasmosis and autoimmune rheumatic diseases in Egyptian patients.

241. Analysis of Within-Host Mathematical Models of Toxoplasmosis That Consider Time Delays.

242. بررسی میزان حضور آنتی بادیهای ضد توکسوپلاسما در دو گروه خانم های باردار با روند طبیعی و خانمهای با سابقه سقط جنین.

243. Exploring IgA variation in serum and aqueous humor of ocular toxoplasmosis patients: relevance for radiotherapy VMAT strategies.

244. TOXOPLASMA GONDII EXPOSURE IN FELINES: AN ALARMING FACTOR TO PUBLIC HEALTH FROM MINEIROS, GOIÁS .

245. miRNA 511_5p is a potential biomarker for ocular toxoplasmosis.

246. Prevalence of Toxoplasmosis in Sheep Slaughtered in Malekan Slaughterhouse by Modified Agglutination Test (MAT).

247. Outcomes of trimethoprim/ sulfamethoxazole treatment for ocular toxoplasmosis in Congolese patients.

248. Therapeutic and antioxidant potential of bionanofactory Ochrobactrum sp.-mediated magnetite and zerovalent iron nanoparticles against acute experimental toxoplasmosis.

249. Polyalthic Acid from Copaifera lucens Demonstrates Anticariogenic and Antiparasitic Properties for Safe Use.

250. Insulinoma: reporte de un caso con resección quirúrgica exitosa.

Catalog

Books, media, physical & digital resources